🚀 ETH – 180 Life Sciences announces rebranding and launches a $425M ETH reserve
Details:
- Raised $425M in a PIPE (private placement) deal.
- Rebranding to ETHZilla Corporation starting August 1.
- Expected diversified yield strategies: staking, lending, liquidity provisioning, private agreements.
- Backed by 60+ major funds from the Ethereum ecosystem, including Polychain, GSR, Lido, EigenLayer, Etherfi, Compound, and others.
180 Life Sciences is a U.S. biotech firm focused on anti-inflammatory and anti-fibrotic drug development, founded by leading scientists from Oxford and Stanford.
👉 Minor adoption impact: mid-cap treasury moves fade quickly; watch SEC's spot-SOL ETF decision by July 31 for institutional on-ramp potential.
